Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Amgen Inc. (AMGN) Q1 2025 Earnings Call Transcript
08:42pm, Thursday, 01'st May 2025
Amgen Inc. (NASDAQ:AMGN ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Justin Claeys - VP, IR Robert Bradway - Chairman, CEO & President Murdo Gordon - EVP, Global Comm
Compared to Estimates, Amgen (AMGN) Q1 Earnings: A Look at Key Metrics
06:30pm, Thursday, 01'st May 2025
While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to
Amgen (AMGN) Tops Q1 Earnings and Revenue Estimates
06:10pm, Thursday, 01'st May 2025
Amgen (AMGN) came out with quarterly earnings of $4.90 per share, beating the Zacks Consensus Estimate of $4.16 per share. This compares to earnings of $3.96 per share a year ago.
Amgen quarterly profit tops Wall Street view, sales up 11%
04:23pm, Thursday, 01'st May 2025
Amgen on Thursday said its first-quarter profit rose 24%, handily exceeding Wall Street expectations, as product sales increased 11% and profit margins widened.
AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
04:01pm, Thursday, 01'st May 2025
THOUSAND OAKS, Calif. , May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025.
5 Dogs of the Dow To Buy This May
09:58am, Thursday, 01'st May 2025
While the strategy involves buying the Dogs of the Dow at the start of January, there are a few still worth betting on as markets regain lost ground.
Beat the Nasdaq With This Cash-Gushing Dividend Stock
08:30am, Thursday, 01'st May 2025
Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech giant Amgen (AMGN 0.82%) exemplifies this strategy with its 3.
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Wednesday, 30'th Apr 2025
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Can Amgen Keep the Beat Streak Alive This Earnings Season?
07:45am, Tuesday, 29'th Apr 2025
Volume growth of AMGN's key drugs like Evenity, Repatha and Kyprolis is expected to have been partially offset by biosimilar/generic competition for mature drugs.
AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
04:01pm, Monday, 28'th Apr 2025
THOUSAND OAKS, Calif. , April 28, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the
Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?
01:11pm, Monday, 28'th Apr 2025
Let's look at five pharma and drug companies, PFE, LLY, AMGN, BIIB and REGN, which are scheduled to release their first-quarter 2025 results later this week.
Amgen (AMGN) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:22am, Monday, 28'th Apr 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Amgen (AMGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
06:05pm, Saturday, 26'th Apr 2025
It's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a particularly opportune time. Dividend-paying companies tend to have strong un
Amgen CEO announces $1 billion in new investments
04:00pm, Friday, 25'th Apr 2025
Amgen chairman and CEO Robert Bradway unpacks the company's investments on 'The Claman Countdown.'
Amgen to expand Ohio biotech manufacturing plant
01:12pm, Friday, 25'th Apr 2025
Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid Trump administratio
